| PACKAGING TYPE: | 9x10 Blister (9 Strips In 1 Box) |
| COMPOSITION: | Each Film Coated Tablet Contains: Empagliflozin 25 Mg, Linagliptin 5 Mg, Excipients Q.s. Colour: Approved colour used. |
| FORMULATION: | Tablet |
| Description: | EMPACON-L 25/5 Tablet is a combination of Empagliflozin 25mg (SGLT2 inhibitor) and Linagliptin 5mg (DPP-4 inhibitor), used for the management of type 2 diabetes mellitus. Empagliflozin works by increasing glucose excretion through urine, while Linagliptin enhances insulin secretion and decreases glucagon levels. The higher strength of Empagliflozin provides stronger glycemic control, making it suitable for patients requiring intensified therapy. |
| Side Effects: | Common side effects may include: Increased urination Urinary tract infections Nasopharyngitis Headache Thirst Serious side effects: Ketoacidosis (rare but serious) Pancreatitis (rare, Linagliptin-related) Kidney function impairment Low blood pressure Severe allergic reactions |
| How to Use: | Take EMPACON-L 25/5 Tablet as prescribed by a healthcare professional Usually taken once daily, preferably in the morning Swallow the tablet whole with water Can be taken with or without food Maintain adequate hydration |
| Precaution: | Monitor kidney function regularly Use cautiously in patients with history of pancreatitis Stay hydrated to prevent dehydration Inform your doctor about other antidiabetic medications Not recommended in type 1 diabetes Avoid use during pregnancy or breastfeeding without medical advice |
| Product Benefits: | Powerful dual-action blood sugar control Enhances insulin secretion and glucose elimination Helps reduce HbA1c levels effectively Supports weight management Provides cardiovascular and kidney protection Once-daily dosing improves patient compliance |
Frequently Asked Questions
It is used for managing blood sugar levels in type 2 diabetes with dual-action therapy.
Yes, it contains a higher dose of Empagliflozin, providing stronger glucose-lowering effects.
It has a low risk when used alone but may increase when combined with other diabetes medications.










